105 related articles for article (PubMed ID: 22579825)
1. Response of Toll-like receptors in experimental Guillain-Barré syndrome: a kinetic analysis.
Gries M; Davies L; Liu Y; Bachhuber A; Spiegel J; Dillmann U; Hartmann T; Fassbender K; Walter S
Neurosci Lett; 2012 Jun; 518(2):154-60. PubMed ID: 22579825
[TBL] [Abstract][Full Text] [Related]
2. Selective expression and cellular localization of pro-inflammatory chemokine ligand/receptor pairs in the sciatic nerves of a severe murine experimental autoimmune neuritis model of Guillain-Barré syndrome.
Xia RH; Yosef N; Ubogu EE
Neuropathol Appl Neurobiol; 2010 Aug; 36(5):388-98. PubMed ID: 20500551
[TBL] [Abstract][Full Text] [Related]
3. Interleukin 23 in acute inflammatory demyelination of the peripheral nerve.
Hu W; Dehmel T; Pirhonen J; Hartung HP; Kieseier BC
Arch Neurol; 2006 Jun; 63(6):858-64. PubMed ID: 16769867
[TBL] [Abstract][Full Text] [Related]
4. Expression of TLR4 and TLR9 mRNA in Lewis rats with experimental allergic neuritis.
Deng YN; Zhou WB
Neuroimmunomodulation; 2007; 14(6):337-43. PubMed ID: 18434754
[TBL] [Abstract][Full Text] [Related]
5. Toll-Like Receptor 2, Toll-Like Receptor 4, Myeloid Differentiation Response Gene 88, and Toll-IL-1 Receptor Domain-Containing Adaptor-Inducing Interferon-γ (TRIF) Selectively Regulate Susceptibility of P0
Brunn A; Mihelcic M; Carstov M; Feind L; Wieser EC; Schmidt J; Utermöhlen O; Deckert M
Am J Pathol; 2017 Jan; 187(1):42-54. PubMed ID: 27842213
[TBL] [Abstract][Full Text] [Related]
6. Toll-like receptor-2, CD14 and heat-shock protein 70 in inflammatory lesions of rat experimental autoimmune neuritis.
Zhang ZY; Zhang Z; Schluesener HJ
Neuroscience; 2009 Mar; 159(1):136-42. PubMed ID: 19162137
[TBL] [Abstract][Full Text] [Related]
7. AUY954, a selective S1P(1) modulator, prevents experimental autoimmune neuritis.
Zhang ZY; Zhang Z; Zug C; Nuesslein-Hildesheim B; Leppert D; Schluesener HJ
J Neuroimmunol; 2009 Nov; 216(1-2):59-65. PubMed ID: 19804913
[TBL] [Abstract][Full Text] [Related]
8. Th1/Th2/Th17/Treg cytokines in Guillain-Barré syndrome and experimental autoimmune neuritis.
Zhang HL; Zheng XY; Zhu J
Cytokine Growth Factor Rev; 2013 Oct; 24(5):443-53. PubMed ID: 23791985
[TBL] [Abstract][Full Text] [Related]
9. FTY720 attenuates lesional interleukin-17(+) cell accumulation in rat experimental autoimmune neuritis.
Zhang ZY; Zhang Z; Schluesener HJ
Neuropathol Appl Neurobiol; 2009 Oct; 35(5):487-95. PubMed ID: 19207263
[TBL] [Abstract][Full Text] [Related]
10. Expression of Toll-like receptors 2, 4 and 9 in patients with Guillain-Barré syndrome.
Wang YZ; Liang QH; Ramkalawan H; Wang YL; Yang YF; Zhou WB; Tian FF; Li J; Yang H
Neuroimmunomodulation; 2012; 19(1):60-8. PubMed ID: 22067623
[TBL] [Abstract][Full Text] [Related]
11. CCR5 deficiency does not prevent P0 peptide 180-199 immunized mice from experimental autoimmune neuritis.
Duan RS; Chen Z; Bao L; Quezada HC; Nennesmo I; Winblad B; Zhu J
Neurobiol Dis; 2004 Aug; 16(3):630-7. PubMed ID: 15262275
[TBL] [Abstract][Full Text] [Related]
12. Atorvastatin ameliorates experimental autoimmune neuritis by decreased Th1/Th17 cytokines and up-regulated T regulatory cells.
Li XL; Dou YC; Liu Y; Shi CW; Cao LL; Zhang XQ; Zhu J; Duan RS
Cell Immunol; 2011; 271(2):455-61. PubMed ID: 21889126
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinases MMP-9 and MMP-7 are expressed in experimental autoimmune neuritis and the Guillain-Barré syndrome.
Kieseier BC; Clements JM; Pischel HB; Wells GM; Miller K; Gearing AJ; Hartung HP
Ann Neurol; 1998 Apr; 43(4):427-34. PubMed ID: 9546322
[TBL] [Abstract][Full Text] [Related]
14. Spinal changes associated with mechanical hypersensitivity in a model of Guillain-Barré syndrome.
Luongo L; Sajic M; Grist J; Clark AK; Maione S; Malcangio M
Neurosci Lett; 2008 May; 437(2):98-102. PubMed ID: 18448252
[TBL] [Abstract][Full Text] [Related]
15. Macrophage migration inhibitory factor (MIF) seems crucially involved in Guillain-Barré syndrome and experimental allergic neuritis.
Nicoletti F; Créange A; Orlikowski D; Bolgert F; Mangano K; Metz C; Di Marco R; Al Abed Y
J Neuroimmunol; 2005 Nov; 168(1-2):168-74. PubMed ID: 16171874
[TBL] [Abstract][Full Text] [Related]
16. The dynamic expression of canonical Wnt/β-catenin signalling pathway in the pathologic process of experimental autoimmune neuritis.
Liu Y; Liu S; Pan S; Gong Q; Yao J; Lu Z
Int J Neurosci; 2020 Nov; 130(11):1109-1117. PubMed ID: 32009498
[No Abstract] [Full Text] [Related]
17. Distribution of inducible nitric oxide synthase and tumor necrosis factor-alpha in the peripheral nervous system of Lewis rats during ascending paresis and spontaneous recovery from experimental autoimmune neuritis.
De La Hoz CL; Castro FR; Santos LM; Langone F
Neuroimmunomodulation; 2010; 17(1):56-66. PubMed ID: 19816058
[TBL] [Abstract][Full Text] [Related]
18. Monocyte chemoattractant protein 1 and chemokine receptor CCR2 productions in Guillain-Barré syndrome and experimental autoimmune neuritis.
Orlikowski D; Chazaud B; Plonquet A; Poron F; Sharshar T; Maison P; Raphaël JC; Gherardi RK; Créange A
J Neuroimmunol; 2003 Jan; 134(1-2):118-27. PubMed ID: 12507779
[TBL] [Abstract][Full Text] [Related]
19. Role of cytokines and Toll-like receptors in the immunopathogenesis of Guillain-Barré syndrome.
Nyati KK; Prasad KN
Mediators Inflamm; 2014; 2014():758639. PubMed ID: 25614713
[TBL] [Abstract][Full Text] [Related]
20. Suppression of autoimmune neuritis in IFN-gamma receptor-deficient mice.
Zhu Y; Ljunggren HG; Mix E; Li HL; van der Meide P; Elhassan AM; Winblad B; Zhu J
Exp Neurol; 2001 Jun; 169(2):472-8. PubMed ID: 11358460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
